GAO Report Casts Shade On Sunscreen Ingredients' Chances With FDA
Executive Summary
Report to key US legislators could boost efforts to revamp approaches to making nonprescription ingredients available.
You may also be interested in...
Spray Sunscreens Stay In FDA Enforcement Discretion Shade
CDER's enforcement policy guidance for OTC monograph sunscreens clarifies that spray sunscreens are included in the agency's enforcement discretion. But CDER closes the door on other dosage forms that it also identified in its 2011 ANPR for whether delivery formats other than lotions, creams or other traditional forms would be eligible for the monograph.
Spray Sunscreens Stay In FDA Enforcement Discretion Shade
CDER's enforcement policy guidance for OTC monograph sunscreens clarifies that spray sunscreens are included in the agency's enforcement discretion. But CDER closes the door on other dosage forms that it also identified in its 2011 ANPR for whether delivery formats other than lotions, creams or other traditional forms would be eligible for the monograph.
Legislators On OTC Monograph Reform: What Took You So Long?
"If the system is broken … my gosh, does it take 45 years for the FDA to say, 'we need help'?" US Rep. Joe Barton, R-TX, asks at House health subcommittee hearing on proposal to streamline the OTC monograph program and establish a user fee program to support FDA's work.